Here are relevant reports on : anaesthesia-drugs-market
-
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs by (CLL, ALL, CML, AML)), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024
The leukemia therapeutics market is projected to reach USD 17.1 billion by 2024, at a CAGR of 6.8%. Market growth is largely driven by the rising prevalence of acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) and increasing approvals of novel & innovative drugs and immunotherapies. The major players in this market are AbbVie (US), Bristol-Myers Squibb (US), Novartis (Switzerland, F. Hoffmann-La Roche (Switzerland), Pfizer (US), Sanofi (France), Amgen (US), Gilead Sciences (US), Takeda Pharmaceutical (Japan), and Celgene (US). Product approvals are a key strategy adopted by key players in order to enhance their dominance in this market.
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Renal Cancer Drugs Market by therapy (targeted therapy, chemotherapy, and immunotherapy), drug class (anti-angiogenesis, mTOR inhibitors, interleukin, and immune checkpoint inhibitors), indication (renal cell carcinoma, urothelial carcinoma, and others), distribution channel (hospitals, specialty & retail pharmacies and others), and region (North America, Europe, Asia Pacific and Rest of the World (RoW) which includes Latin America and Middle East & Africa) – global forecasts to 2027
The renal cancer drugs market is projected to reach USD 8 billion by 2027 from USD 6 billion in 2022, at a CAGR of 6% during the forecast period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User ((Profit: Pharma, Payer, Hospital), (Non-Profit: Govt)) & Region - Global Forecast to 2030
The global patient registry software market, valued at US$2.06 billion in 2024, stood at US$2.25 billion in 2025 and is projected to advance at a resilient CAGR of 9.8% from 2025 to 2030, culminating in a forecasted valuation of US$3.61 billion by the end of the period. The robust growth in registry software solutions is driven by a focus on patient-centric care and value-based healthcare delivery. Due to their flexibility and cost-effectiveness, the demand for public databases and cloud-based models is increasing.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Grignard Reagents Market by Product Type (Alkyl Grignard Reagents, Vinyl Grignard Reagents, Aryl Grignard Reagents), Application (APIs & Drugs, Agrochemicals, Polymer Synthesis & Functionalization), End-use Industry (Pharmaceutical & Biotechnology, Agriculture, Chemical, Flavors & Fragrances, Research), and Region - Global Forecast to 2030
The grignard reagents market is expected to grow from USD 5.07 billion in 2025 to USD 6.67 billion in 2030, at a CAGR of 5.6% during the forecast period. Prominent companies in this market include Merck KGaA (Germany), Albemarle Corporation (US), WeylChem International GmbH (Germany), HOKKO CHEMICAL INDUSTRY CO., LTD. (Japan), CHEMIUM srl (Belgium), FAR Chemical (US), PMC Group, Inc (US), Boulder Scientific Group (US), Neogen Chemicals Ltd (India), Tokyo Chemical Industry (India) Pvt. Ltd. (India), Optima Chem (US), Shaoxing Shangyu Hualun Chemical Co., Ltd. (China), Nanjing Freehoo Chemical Technology Co., Ltd (China), Chemische Fabrik Karl Bucher GmbH (Germany), and Jiangsu Changjili New Energy Technology Co., Ltd. (China).
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Global Forecast to 2022
The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Peptide and Anticoagulant Drugs Market by Type (Hormonal (Insulin, Teriparatide, Calcitonin), Antibiotic (Colistin, Cycloserine), Low molecular weight heparin (Enoxaparin Sodium, Heparin Sodium), Application (Diabetes, Cancer) - Global Forecast to 2022
The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%. Factors such as increasing prevalence of chronic diseases, rising aging population, and increasing healthcare expenditure are contributing to the growth of this market. The Indian anticoagulant drugs market is expected to reach USD 170.2 Million in 2022 from USD 127.8 Million in 2016 and is expected to register a CAGR of 4.9%. Factors such as incidence of coagulation disorders and government support for pharmaceutical companies are contributing to the growth of this market. Some of the major players operating in the Indian anticoagulant drugs market are Sanofi (France), Emcure Pharmaceutical Pvt. Ltd. (India), Cipla Ltd. (India), Bharat Serum (India), Pfizer Inc. (US), Abbott Laboratories (U.S.), Lupin Ltd. (India), Dr. Reddy’s Laboratories (India), Intas Pharmaceuticals Ltd. (India), Samarth Life Sciences (India), Claris Lifesciences Limited (India), Gland Pharma Limited (India), Mylan Pharmaceutical (India), Torrent Pharmaceuticals (India), Micro Labs Ltd. (India), and VHB Lifesciences (India).
- Published: August 2017
- Price: $ 7150
- TOC Available:
-
Alginates and Derivatives Market by Type (Sodium Alginate, Calcium Alginate, Potassium Alginate, PGA), Application (Food & Beverages, Industrial, Pharmaceuticals), Form (Powder, Liquid, Gel Form), and Region - Global Forecast to 2028
The alginates and derivatives market size is projected to reach USD 651 million by 2028, at a CAGR of 5.7% during the forecast period. Key players operating in the alginates and derivatives market include Cargill Inc. (US), KIMICA Corporation (Japan), FMC Corporation (US), E.I. DuPont de Nemours and Company (US), and The Dow Chemical Company (UK). Other players include Brenntag AG (Germany), Döhler Group (Germany), Penford Corporation (US), Ashland Inc. (US), Snap Natural & Alginate Products Pvt. Ltd (India), Bright Moon Group (China), and Dastech International (US). These players in this market are focusing on increasing their presence through expansion and collaboration. These companies have a strong presence in North America, Asia Pacific, and Europe.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Lithium Metal Battery Market by Type (Solid-State, Titanate, Sulfur, Air, Metal-Polymer), Operational Type, Capacity Form, Application and Region (Asia Pacific, North America, Europe, South America & MEA) - Global Forecast to 2030
The lithium metal battery market is projected to grow from USD 604.7 million in 2024 to USD 1,163.6 million by 2030, at a CAGR of 17.8% during the forecast period. The major market players include QuantumScape Battery, Inc. (US), Solid Power Inc. (US), Ion Storage Systems (US), Sion Power Corporation (US), Northvolt AB (Sweden), Poly Plus (France), BYD Company Ltd. (China), Sepion Technologies (US), SES AI Corporation (US), Bluesolutions AS (Norway), Solithor (Beligium) and Factorial Inc. (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Biodegradable Films Market by Type (PLA, Starch Blends, Biodegradable Polyesters, PHA), Application (Food Packaging, Agriculture & Horticulture, Cosmetic & Personal Care Products Packaging, Industrial Packaging) and Region - Global Forecast to 2026
The biodegradable films market is expected to grow from USD 1.0 billion in 2021 to USD 1.4 billion by 2026, at a CAGR of 7.2% during the forecast period. BASF SE (Germany), Futamura Chemical Co. Ltd. (Japan), Taghleef Industries (UAE), Walki Group Oy (Finland), Kingfa Sci. & Tech. Co., Ltd. (China), BioBag Americas, Inc. (US), Avery Dennison Corporation (US), Plascon Group (US), Bi-Ax International Inc. (Canada), Cortec Corporation (US), Clondalkin Group (Netherlands), TRIOWORLD INDUSTRIER AB (Sweden), Groupe Barbier (France), Paco Label (US), Layfield Group (Canada), and Polystar Plastics Ltd. (UK) are the key players in biodegradable films market.
- Published: January 2022
- Price: $ 4950
- TOC Available:
-
Hyperscale Computing Market by Offering (Solutions and Services), Application (Cloud Computing, Big Data, IoT), Vertical (Manufacturing, Government & Defense, BFSI, IT & Telecom, Retail & Consumer Goods) and Region - Global Forecast to 2028
The hyperscale computing market size is projected to reach USD 109.2 billion by 2028 at a compound annual growth rate (CAGR) of 21.7% during the forecast period. Some of the significant hyperscale computing market vendors are AWS (US), Google (US), Microsoft Corporation (US), IBM Corporation (US), Oracle Corporation (US), HPE (US), Alibaba Cloud (China), Tencent Cloud (China), Salesforce (US), Huawei (China), Viavi Solutions (US), Broadcom (US), AFL Hyperscale (US), OVHcloud (France), Iron Mountain (US), DigitalOcean (US), Rackspace (US), NTT Communications (Japan), and Digital Reality (US).
- Published: August 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
